StonvexLoading…
StonvexCore line items from FLGT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $322.67M | $283.47M | $289.21M | $618.97M |
Operating Income | $-91.10M | $-73.92M | $-195.53M | $178.53M |
Net Income | $-60.51M | $-42.71M | $-167.82M | $143.40M |
EPS (Diluted) | $-1.97 | $-1.41 | $-5.63 | $4.63 |
Total Assets | $1.21B | $1.22B | $1.24B | $1.39B |
Total Liabilities | $106.81M | $90.81M | $102.04M | $116.18M |
Cash & Equivalents | $50.19M | $55.14M | $97.47M | $79.51M |
Free Cash Flow OCF − CapEx | $-124.21M | $-19.25M | $4.80M | $234.75M |
Shares Outstanding | 31.08M | 30.84M | 29.65M | 29.44M |